World Health Organization, “Obesity. Preventing and managing the global epidemic, Report of a WHO consultation (WHO Technical Report Series 894),” 2000. http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/
 Centre for Public Health Excellence at NICE (UK), National Collaborating Centre for Primary Care (UK), “Obesity: The Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children,” National Institute for Health and Clinical Excellence (UK) (NICE Clinical Guidelines, No. 43), 2006. http://www.ncbi.nlm.nih.gov/books/NBK63696/
 "FDA Briefing Document NDA 21-888 Zimulti (rimonabant) Tablets, 20 mg Sanofi Aventis Advisory Committee" (PDF),” Food and Drug Administration, 2007. http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4306b1-fda-backgrounder.pdf.
 R. M. Pinder, R. N. Brogden, P. R. Sawyer, T. M. Speight and G. S. Avery, “Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity,” Drugs, Vol. 10, No. 4, 1975, pp. 241-323.
 H. M. Connolly, J. L. Crary, M. D. McGoon, D. D. Hensrud, B. S. Edwards, W. D. Edwards and H. V. Schaff, “Valvular heart disease associated with fenfluramine-phentermine,” New England Journal of Medicine, Vol. 337, No. 9, 1997, pp. 581-588.
 J. P. Park, J. H. Kim, M. K. Park and J. W. Yun, “Potential agents for cancer and obesity treatment with herbal medicines from the green garden,” Biotechnology and Bioprocess Engineering, Vol. 16, No. 6, 2011, pp. 1065-1076.
 R. P. Pickering, B. F. Grant, S. P. Chou, and W. M. Compton, “Are overweight, obesity, and extreme obesity associated with psychopathology? Results from the national epidemiologic survey on alcohol and related conditions,” Journal of Clinical Psychiatry, Vol. 68, No. 7, 2007, pp. 998-1009.
 Britz, W. Siegfried, A. Ziegler, C. Lamertz, B. M. Herpertz-Dahlmann, H. Remschmidt, H. U. Wittchen and J. Hebebrand, “Rates of psychiatric disorders in a clinical study group of adolescents with extreme obesity and in obese adolescents ascertained via a population based study,” International Journal of Obesity related metabolism and disorder, Vol. 24, No. 12, 2000, pp. 1707-1714.
 J. Lee, K. Chae, J. Ha, B.Y. Park, H. S. Lee, S. Jeong, M.Y. Kim and M. Yoon, “Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaries in high-fat diet-induced obese mice,” Journal of Ethnopharmacology, Vol. 115, No. 2, 2008, pp. 263-270.
 T. Tsujita, H. Takaichi, T. Takaku, S. Aoyama and J. Hiraki, “Antiobesity action of epolylysine, a potent inhibitor of pancreatic lipase,” Journal of Lipid Research, Vol. 47, No. 8, 2006, pp. 1852-1858.
 L. K. Han, Y. N. Zheng, M. Yoshikawa, H. Okuda and Y. Kimura, “Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizome,” BMC Complementary and Alternative Medicine,” Vol. 5, No. 9, 2005, pp. 1-10.
 L. K. Han, B. J. Xu, Y. Kimura, Y. Zheng and H. Okuda, “Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity,” The Journal of Nutrition, Vol. 130, No. 11, 2000, pp. 2760-2764.
 E. Kishino, T. Ito, K. Fujita and Y. Kiuchi, “A mixture of the Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces the accumulation of visceral fat mass in mice and rats with high-fat diet-induced obesity,” Journal of Nutrition, Vol. 136, No. 2, 2006, pp. 433-439.
 D. A. Moreno, N. Ilic, A. Poulev and I. Raskin, “Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters,” Life Sciences, Vol. 78, No. 24, 2006, pp. 2797-2803.
 H. Shimoda, E. Seki and M. Aitani, “Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice,” BMC Complementary and Alternative Medicine, Vol. 6, No. 9, 2006, pp. 1-9.
 M. Nakai, Y. Fukui, S. Asami, Y. Toyo-da-Ono, T. Iwashita, H. Shibata, T. Mitsunaga, F. Hashimoto and Y. Kiso, “Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro,” Journal of Agricultural and Food Chemistry, Vol. 53, No. 11, 2005, pp. 4593-4598.
 H. K. Kim, M. Della-Fera, J. Lin and C.A. Baile, “Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes,” The Journal of nutrition, Vol. 136, No. 12, 2006, pp. 2965-2969.
 Y. B. Lombardo and A. G. Chicco, “Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review,” The Journal of Nutritional Biochemistry, Vol. 17, No. 1, 2006, pp. 1-13.
 T. Murase, A. Nagasawa, J. Suzuki, T. Hase and I. Tokimitsu, “Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver,” International Journal of Obesity and Related Metabolic Disorders, Vol. 26, No. 11, 1999, pp. 1459-1464.
 K. M. Hargrave, C. Li, B. J. Meyer, S. D. Kachman, D. L. Hartzell, M. A. Della-Fera, J. L. Miner and C. A. Baile, “Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic Acid in mice,” Obesity Research, Vol. 10, No. 12, 2002, pp. 1284-1290.
 J. T. Hwang, I. J. Park, J. I. Shin, Y. K. Lee, S. K. Lee, H. W. Baik, J. Ha and O. J. Park, “Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase,” Biochemical and Biophysical Research Com-munication, Vol. 338, No. 2, 2002, pp. 694-699.
 C. L. Hsu and G. C. Yen, “Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity,” Molecular Nutrition and Food Research, Vol. 50, No. 11, 2006, pp. 1072-1079.
 J. Y. Yang, M. A. Della-Fera, D. L. Hartzell, C. Nelson-Dooley, D. B. Hausman and C. A. Baile, “Esculetin induces apoptosis and inhibits adipogenesis in 3T3-L1 cells,” Obesity, Vol. 14, No. 10, 2006, pp. 1691-1699.
 J. Y. Yang, M. A. Della-Fera, S. Rayalam, S. Ambati, D. L. Hartzell, H. J. Park and C. A. Baile, “Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin,” Life Sciences, Vol. 82, No. 19-20, 2008, pp. 1032-1039.
 F. Picard, M. Kurtev, N. Chung, A. Topark-Ngarm, T. Senawong, R. Machado De Oliveira, M. Leid, M. W. McBurney and L. Guarente, “Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma,” Nature, Vol. 429, No. 6993, 2004, pp. 771-776.
 M. V. Kumar, G. D. Sunvold and P. J. Scarpace, “Dietary vitamin a supplementation in rats: suppression of leptin and induction of UCP1 mRNA,” Journal of Lipid Research, Vol. 40, No. 5, 1999, pp. 824-829.
 S. S. Yoon, Y. H. Rhee, H. J. Lee, E. O. Lee, M. H. Lee, K. S. Ahn, H. T. Lim and S. H. Kim, “Uncoupled protein 3 and p38 signal pathways are involved in anti-obesity activity of Solanum tuberosum L. cv. Bora Valley,” Journal of Ethnopharmacology, Vol. 118, No. 3, 2008, pp. 396-404.
 G. Dulloo, “Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis,” International Journal of Obesity and Related Metabolic Disorders, Vol. 17, No. 1, 1993, pp. 35–40.
 S. Racotta, J. Leblanc and D. Richard, “The effect of caffeine on food intake in rats: involvement of corticotro-pin-releasing factor and the sympatho-adrenal system,” Pharmacology, Biochemistry, and Behavior, Vol. 48, No. 4, 1994, pp. 887-892.
 T. Kawada, T. Watanabe, T. Takaishi, T. Tanaka and K. Iwai, “Capsaicin-induced beta-adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization,” Proceeding of the Society for Experimental Biology and Medicine, Vol. 183, No. 2, 1986, pp. 250-256.
 D. Langin, “Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome,” Pharmacological Research, Vol. 53, No. 6, 2006, pp. 482-491.
 E. Ohkoshi, H. Miyazaki, K. Shindo, H. Watanabe, A. Yoshida and H. Yajima, “Constituents from the leaf of Nelumbo nucifera stimulate lipolysis in the white adipose tissue of mice,” Planta Medica, Vol. 73, No. 12, 2007, pp. 1255-1259.
 F. Di Pierro, A. B. Menghi, A. Barreca, M. Lucarelli and A. Calandrelli, “Green select Phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial,” Alternative Medicine Reviews, Vol. 14, No. 2, 2009, pp. 154-160.
 S. O. Kim, S. J. Yun, B. Jung, E. H. Lee, D. H. Hahm, I. Shim and H. J. Lee, “ Hypolipidemic effects of crude extract of adlay seed (Coix lachrymajobi var. mayuen) in obesity rat fed high fat diet: relations of TNF-alpha and leptin mRNA expressions and serum lipid levels,” Life Sciences, Vol. 75, No. 11, 2004, pp. 1391-1404.
 H. Tecott, L. M. Sun, S. F. Akana, A. M. Strack, D. H. Lowenstein, M. F. Dallman and D. Julius, “Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors,” Nature, Vol. 374, No. 6522, pp. 542–546.
 H. S. Moon, H. G. Lee, Y. J. Choi, T. G. Kim and C. S. Cho, “Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity,” Chemico-Biological Interactions, Vol. 167, No. 2, 2007, pp. 85-98.
 R. T. Borchardt and J. A. Huber, “Catechol O-methyltransferase. 5. Structure– activity relationships for inhibition by flavonoids,” Journal of Medical Chemistry, Vol. 18, No. 1, 1975, pp. 120-122.
 Boschmann and F. Thielecke, “The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study,” Journal of the American Collage of Nutrition, Vol. 26, No. 4, 2007, pp. 389-395.
 S. H. Cha, M. Wolfgang, Y. Tokutake, S. Chohnan and M. D. Lane, “Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 44, 2008, pp. 16871-16875.
 K. Singh, P. S. Patki, and S. K. Mitra, “Evaluation of clinical efficacy of AyurSlim on body weight, body mass index, lipid profile and skin fold thickness: A Phase IV clinical study,” The Antiseptic, Vol. 105, No. 5, 2005, pp. 241-243.
 M. P. Godard, B. A. Johnson, and S. R. Richmond, “Body Composition and Hormonal Adaptations Associated with Forskolin Consumption in Overweight and Obese Men,” Obesity Research, Vol. 13, No. 8, 2005, pp. 1335-1343.
 S. Henderson, B. Magu, C. Rasmussen, S. Lan-caster, C. Kerksick, P. Smith, C. Melton, P. Cowan, M. Greenwood, C. Earnest, A. Almada, P. Milnor, T. Magrans, R. Bowden, S. Ounpraseuth, A. Thomas, and R. B. Kreider, “Effects of Coleus Forskohlii Supplementation on Body Composition and Hematological Profiles in Mildly Overweight Women,” Journal of International Society for Sports Nutrition, Vol. 2, No. 2, 2005, pp. 54-62.
 J. Udani, M. Hardy, and D.C. Madsen, “Blocking Carbohydrate Absorption and Weight Loss: A Clinical Trial Using Phase 2TM Brand Proprietary Fractionated White Bean Extract,” Alternative Medicine Review, Vol. 9, No. 1, 2004, pp. 63-69.
 V. Ignjatovic, E. Ogru, M. Heffernan, R. Libinaki, Y. Lim, and F. Ng, “Studies on the use of "slimax", a chinese herbal mixture, in the treatment of human obesity,” Pharmaceutical Biology, Vol. 38, No. 1, 2000, pp. 30-35.
 E. Toromanyan, G. Aslanyan, E. Amroyan, E. Gabrielyan, and A. Panossian, “Efficacy of Slim339in Reducing Body Weight of Overweight and Obese Human Subjects,” Phytotherapy Research, Vol. 21, No. , 2007, pp. 1177-1181.